FRANKFORT, Ky. (LEX 18) — President Trump's proposed 100% tariff on imported drugs has Kentucky pharmacists worried about potential disruptions to patient care and pharmacy operations.

The tariff, originally set to take effect October 1, would apply to brand-name or patented pharmaceutical products unless drug makers build manufacturing plants in the United States. The implementation is currently on hold as the new tax is still being prepared.

Dr. Ben Mudd, executive director of the Kentucky Pharmacists Association, believes the announcement was strategic.

"It was a tactic to try to bring the drug manufacturers to the negotiating table," Mudd said.

The approach appears to be working. The White House brokered a deal with Pfizer to lower prescription drug prices in the United States thro

See Full Page